CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bellas, R. E.
Right arrow Articles by Sonenshein, G. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bellas, R. E.
Right arrow Articles by Sonenshein, G. E.
Cell Growth & Differentiation Vol. 10, 287-294, May 1999
© 1999 American Association for Cancer Research

Nuclear Factor {kappa}B Cooperates with c-Myc in Promoting Murine Hepatocyte Survival in a Manner Independentof p53 Tumor Suppressor Function1

Robert E. Bellas and Gail E. Sonenshein2

Department of Biochemistry, Boston University School of Medicine, Boston, Massachusetts 02118

The nuclear factor-{kappa}B (NF-{kappa}B)/Rel family of transcription factors has been implicated in promoting hepatocyte survival during development and liver regeneration following partial hepatectomy. Inhibition of NF-{kappa}B/Rel activity by microinjection of the specific inhibitor I{kappa}B-{alpha} induces apoptosis in a nontransformed normal murine hepatocyte (NMH) cell line. Here, we demonstrate that apoptosis resulting from such inhibition requires down-regulation of the c-Myc proto-oncoprotein and occurs independently of p53 tumor suppressor function. NMH cells plated at low density displayed low sensitivity to I{kappa}B-{alpha}-induced apoptosis and high levels of c-Myc protein expression. Comicroinjection of I{kappa}B-{alpha} with the c-Myc antagonist Mad1-glutathione S-transferase fusion protein greatly enhanced cell death. In addition, transient cotransfection of low-density NMH and AML12 hepatocytes with vectors expressing I{kappa}B-{alpha} and antisense c-myc transcripts promoted cell death. Conversely, ectopic c-myc expression significantly decreased the extent of cell death in NMH cells plated at saturating density, which were characterized by very low levels of c-Myc and high susceptibility to NF-{kappa}B inhibition-induced cell death. Finally, I{kappa}B-{alpha}-induced apoptosis was unaffected in NMH cells expressing a dominant negative p53 protein. Thus, NF-{kappa}B cooperates with c-Myc in promoting murine hepatocyte survival in a manner independent of p53 tumor suppressor activity.




This article has been cited by other articles:


Home page
Mol Cancer ResHome page
A. Hultquist, C. Cetinkaya, S. Wu, A. Castell, A. Erlandsson, and L.-G. Larsson
Mad 1 Inhibits Cell Growth and Proliferation but Does Not Promote Differentiation or Overall Survival in Human U-937 Monoblasts
Mol. Cancer Res., August 1, 2004; 2(8): 464 - 476.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
Y. Y. Sautin, J. M. Crawford, and S. I. Svetlov
Enhancement of survival by LPA via Erk1/Erk2 and PI 3-kinase/Akt pathways in a murine hepatocyte cell line
Am J Physiol Cell Physiol, December 1, 2001; 281(6): C2010 - C2019.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. Soriani, N. A. Williams, and T. R. Hirst
Escherichia coli Enterotoxin B Subunit Triggers Apoptosis of CD8+ T Cells by Activating Transcription Factor c-Myc
Infect. Immun., August 1, 2001; 69(8): 4923 - 4930.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1999 by the American Association of Cancer Research.